(Q36656437)

15 August 2017

1 reference

title

Disease-modifying therapies in Alzheimer's disease: how far have we come? (English)

1 reference

15 August 2017

0 references

Michael Hüll

1

1 reference

15 August 2017

Mathias Berger

series ordinal

2

1 reference

15 August 2017

Michael Heneka

series ordinal

3

1 reference

15 August 2017

1 January 2006

1 reference

15 August 2017

1 reference

15 August 2017

66

1 reference

15 August 2017

2075-2093

1 reference

15 August 2017

16

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-200666160-00004

15 August 2017

0 references

cites work

Unregulated inflammation shortens human functional longevity

1 reference

12 December 2020

Molecular basis of neuroprotective activities of rasagiline and the anti-Alzheimer drug TV3326 [(N-propargyl-(3R)aminoindan-5-YL)-ethyl methyl carbamate].

1 reference

12 December 2020

Nonsteroidal anti-inflammatory drugs and peroxisome proliferator-activated receptor-gamma agonists modulate immunostimulated processing of amyloid precursor protein through regulation of beta-secretase.

1 reference

12 December 2020

Matrix metalloproteinase-9 degrades amyloid-beta fibrils in vitro and compact plaques in situ

1 reference

12 December 2020

Anti-inflammatory drugs: a hope for Alzheimer's disease?

1 reference

12 December 2020

Clinical trials in AD: are current formats and outcome measures adequate?

1 reference

12 December 2020

Somatostatin regulates brain amyloid beta peptide Abeta42 through modulation of proteolytic degradation.

1 reference

12 December 2020

Barriers to drug discovery and development for Alzheimer disease.

1 reference

12 December 2020

Acute treatment with the PPARgamma agonist pioglitazone and ibuprofen reduces glial inflammation and Abeta1-42 levels in APPV717I transgenic mice

1 reference

12 December 2020

Dissection of amyloid-beta precursor protein-dependent transcriptional transactivation.

1 reference

12 December 2020

Inhibition of Alzheimer beta-fibrillogenesis by melatonin

1 reference

12 December 2020

The expanding role of BDNF: a therapeutic target for Alzheimer's disease?

1 reference

12 December 2020

Secretases as targets for the treatment of Alzheimer's disease: the prospects

1 reference

12 December 2020

Age- and concentration-dependent neuroprotection and toxicity by TNF in cortical neurons from beta-amyloid.

1 reference

12 December 2020

Short amyloid-beta (Abeta) immunogens reduce cerebral Abeta load and learning deficits in an Alzheimer's disease mouse model in the absence of an Abeta-specific cellular immune response.

1 reference

12 December 2020

Memantine for dementia

1 reference

12 December 2020

Indomethacin for the treatment of Alzheimer's disease patients

1 reference

12 December 2020

Novel therapeutic approach for the treatment of Alzheimer's disease by peripheral administration of agents with an affinity to beta-amyloid.

1 reference

12 December 2020

Non-Fc-mediated mechanisms are involved in clearance of amyloid-beta in vivo by immunotherapy.

1 reference

12 December 2020

Metal ion-dependent effects of clioquinol on the fibril growth of an amyloid {beta} peptide

1 reference

12 December 2020

Effects of a gamma-secretase inhibitor in a randomized study of patients with Alzheimer disease.

1 reference

12 December 2020

Relationship between beta amyloid peptide generating molecules and neprilysin in Alzheimer disease and normal brain

1 reference

12 December 2020

Global prevalence of dementia: a Delphi consensus study

1 reference

12 December 2020

Ironic fate: can a banned drug control metal heavies in neurodegenerative diseases?

1 reference

12 December 2020

Microglial EP2 as a new target to increase amyloid beta phagocytosis and decrease amyloid beta-induced damage to neurons

1 reference

12 December 2020

Cerebrolysin in Alzheimer's disease: a randomized, double-blind, placebo-controlled trial with a neurotrophic agent.

1 reference

12 December 2020

Design and analysis of two-period studies of potentially disease-modifying treatments.

1 reference

12 December 2020

Treatment of Alzheimer's disease with clioquinol

1 reference

12 December 2020

Long-term donepezil treatment in 565 patients with Alzheimer's disease (AD2000): randomised double-blind trial.

1 reference

12 December 2020

Mood stabilizers in Alzheimer's disease: symptomatic and neuroprotective rationales

1 reference

12 December 2020

Intravenous immunoglobulins containing antibodies against beta-amyloid for the treatment of Alzheimer's disease

1 reference

12 December 2020

Naphthyl and coumarinyl biarylpiperazine derivatives as highly potent human beta-secretase inhibitors. Design, synthesis, and enzymatic BACE-1 and cell assays.

1 reference

12 December 2020

Nonviral Abeta DNA vaccine therapy against Alzheimer's disease: long-term effects and safety

1 reference

12 December 2020

MRI as a biomarker of disease progression in a therapeutic trial of milameline for AD.

1 reference

12 December 2020

Anthraquinones inhibit tau aggregation and dissolve Alzheimer's paired helical filaments in vitro and in cells

1 reference

12 December 2020

The non-amyloidogenic pathway: structure and function of alpha-secretases

1 reference

12 December 2020

A disintegrin-metalloproteinase prevents amyloid plaque formation and hippocampal defects in an Alzheimer disease mouse model

1 reference

12 December 2020

Clioquinol mediates copper uptake and counteracts copper efflux activities of the amyloid precursor protein of Alzheimer's disease

1 reference

12 December 2020

Harnessing chaperones to generate small-molecule inhibitors of amyloid beta aggregation

1 reference

12 December 2020

Selegiline for Alzheimer's disease

1 reference

12 December 2020

Do statins reduce risk of incident dementia and Alzheimer disease? The Cache County Study.

1 reference

12 December 2020

Presenilin-dependent intramembrane proteolysis of CD44 leads to the liberation of its intracellular domain and the secretion of an Abeta-like peptide

1 reference

12 December 2020

Linking receptor-mediated endocytosis and cell signaling: evidence for regulated intramembrane proteolysis of megalin in proximal tubule

1 reference

12 December 2020

Production of the Alzheimer amyloid beta protein by normal proteolytic processing

1 reference

12 December 2020

Estrogen-containing hormone therapy and Alzheimer's disease risk: understanding discrepant inferences from observational and experimental research

1 reference

12 December 2020

Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study

1 reference

12 December 2020

Contribution of inflammatory processes to Alzheimer's disease: molecular mechanisms

1 reference

12 December 2020

Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red.

1 reference

12 December 2020

A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study.

1 reference

12 December 2020

The role of biomarkers in clinical trials for Alzheimer disease

1 reference

12 December 2020

A novel phospholipid derivative of indomethacin, DP-155 [mixture of 1-steroyl and 1-palmitoyl-2-{6-[1-(p-chlorobenzoyl)-5-methoxy-2-methyl-3-indolyl acetamido]hexanoyl}-sn-glycero-3-phosophatidyl [corrected] choline], shows superior safety and simil

1 reference

12 December 2020

Epitope and isotype specificities of antibodies to beta -amyloid peptide for protection against Alzheimer's disease-like neuropathology

1 reference

12 December 2020

Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo

1 reference

12 December 2020

Invasion of hematopoietic cells into the brain of amyloid precursor protein transgenic mice.

1 reference

12 December 2020

Prostaglandin E2 EP1 receptors: downstream effectors of COX-2 neurotoxicity.

1 reference

12 December 2020

1 reference

12 December 2020

A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study Group

1 reference

12 December 2020

The beta-amyloid precursor protein (APP) and Alzheimer's disease: does the tail wag the dog?

1 reference

12 December 2020

Implication of APP secretases in notch signaling

1 reference

12 December 2020

Nerve growth factor: from animal models of cholinergic neuronal degeneration to gene therapy in Alzheimer's disease

1 reference

12 December 2020

Anti-inflammatory actions of peroxisome proliferator-activated receptor gamma agonists in Alzheimer's disease

1 reference

12 December 2020

Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial

1 reference

12 December 2020

Cerebrospinal fluid protein biomarkers for Alzheimer's disease

1 reference

12 December 2020

Neurotrophic factor therapy--prospects and problems

1 reference

12 December 2020

Peroxisome proliferator-activated receptor gamma agonists protect cerebellar granule cells from cytokine-induced apoptotic cell death by inhibition of inducible nitric oxide synthase

1 reference

12 December 2020

The microglial phagocytic role with specific plaque types in the Alzheimer disease brain

1 reference

12 December 2020

Amyloid at the cutting edge: activation of alpha-secretase prevents amyloidogenesis in an Alzheimer disease mouse model

1 reference

12 December 2020

Amyloid-beta metal interaction and metal chelation.

1 reference

12 December 2020

The role of P-glycoprotein in cerebral amyloid angiopathy; implications for the early pathogenesis of Alzheimer's disease.

1 reference

12 December 2020

Vitamin E for Alzheimer's disease

1 reference

12 December 2020

Toward Alzheimer therapies based on genetic knowledge

1 reference

12 December 2020

Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease

1 reference

12 December 2020

Nimodipine for primary degenerative, mixed and vascular dementia

1 reference

12 December 2020

The development of anti-amyloid therapy for Alzheimer's disease : from secretase modulators to polymerisation inhibitors

1 reference

12 December 2020

An attenuated immune response is sufficient to enhance cognition in an Alzheimer's disease mouse model immunized with amyloid-beta derivatives.

1 reference

12 December 2020

Long-term protective effect of atorvastatin in permanent focal cerebral ischemia

1 reference

12 December 2020

The effects of Neotrofin on septodentate sprouting after unilateral entorhinal cortex lesions in rats.

1 reference

12 December 2020

Activity of flurbiprofen and chemically related anti-inflammatory drugs in models of Alzheimer's disease

1 reference

12 December 2020

D-cycloserine for Alzheimer's disease.

1 reference

12 December 2020

Metal and inflammatory targets for Alzheimer's disease

1 reference

12 December 2020

Treatment with simvastatin in normocholesterolemic patients with Alzheimer's disease: A 26-week randomized, placebo-controlled, double-blind trial

1 reference

12 December 2020

LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription

1 reference

12 December 2020

Gamma-secretase/presenilin inhibitors for Alzheimer's disease phenocopy Notch mutations in Drosophila.

1 reference

12 December 2020

Sustained improvement of cognition and global function in patients with moderately severe Alzheimer's disease: a double-blind, placebo-controlled study with the neurotrophic agent Cerebrolysin.

1 reference

12 December 2020

Partial loss of presenilins causes seborrheic keratosis and autoimmune disease in mice

1 reference

12 December 2020

Vitamin C and Vitamin E for Alzheimer's Disease

1 reference

12 December 2020

Nonsteroidal Anti-Inflammatory Drugs Can Lower Amyloidogenic Aß 42 by Inhibiting Rho

1 reference

12 December 2020

Antibodies from a DNA peptide vaccination decrease the brain amyloid burden in a mouse model of Alzheimer's disease.

1 reference

12 December 2020

1,1'-Xylyl bis-1,4,8,11-tetraaza cyclotetradecane: a new potential copper chelator agent for neuroprotection in Alzheimer's disease. Its comparative effects with clioquinol on rat brain copper distribution.

1 reference

12 December 2020

Alzheimer's Abeta vaccination of rhesus monkeys (Macaca mulatta).

1 reference

12 December 2020

Antioxidant vitamin intake and risk of Alzheimer disease

1 reference

12 December 2020

Amyloid-beta peptides interact with plasma proteins and erythrocytes: implications for their quantitation in plasma

1 reference

12 December 2020

Standardization of measurement of beta-amyloid(1-42) in cerebrospinal fluid and plasma.

1 reference

12 December 2020

Non-steroidal anti-inflammatory drugs (NSAIDs) and other anti-inflammatory agents in the treatment of neurodegenerative disease

1 reference

12 December 2020

Core biological marker candidates of Alzheimer's disease - perspectives for diagnosis, prediction of outcome and reflection of biological activity

1 reference

12 December 2020

Peroxisome proliferator-activated receptors alpha and gamma are activated by indomethacin and other non-steroidal anti-inflammatory drugs

1 reference

12 December 2020

A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease

1 reference

12 December 2020

Glycogen synthase kinase 3: a drug target for CNS therapies

1 reference

12 December 2020

Glutamate-mediated excitotoxicity and neurodegeneration in Alzheimer's disease

1 reference

12 December 2020

Amelioration of amyloid load by anti-Abeta single-chain antibody in Alzheimer mouse model

1 reference

12 December 2020

Antibodies against beta-amyloid slow cognitive decline in Alzheimer's disease.

1 reference

12 December 2020

The neuroprotective effects of Cerebrolysin in a transgenic model of Alzheimer's disease are associated with improved behavioral performance.

1 reference

12 December 2020

The cell biology of Alzheimer's disease: uncovering the secrets of secretases

1 reference

12 December 2020

Long-term efficacy and safety of galantamine in patients with mild-to-moderate Alzheimer's disease: multicenter trial

1 reference

12 December 2020

Abeta vaccination effects on plaque pathology in the absence of encephalitis in Alzheimer disease

1 reference

12 December 2020

Reductions in beta-amyloid concentrations in vivo by the gamma-secretase inhibitors BMS-289948 and BMS-299897.

1 reference

12 December 2020

Alzheimer's disease-like neuropathology of gene-targeted APP-SLxPS1mut mice expressing the amyloid precursor protein at endogenous levels

1 reference

12 December 2020

The mouse peroxisome proliferator activated receptor recognizes a response element in the 5' flanking sequence of the rat acyl CoA oxidase gene

1 reference

12 December 2020

Inflammation and Alzheimer's disease

1 reference

12 December 2020

NSAIDs and enantiomers of flurbiprofen target gamma-secretase and lower Abeta 42 in vivo

1 reference

12 December 2020

The molecular basis of memantine action in Alzheimer's disease and other neurologic disorders: low-affinity, uncompetitive antagonism

1 reference

12 December 2020

Atorvastatin for the treatment of mild to moderate Alzheimer disease: preliminary results.

1 reference

12 December 2020

Transgenic mouse models of Alzheimer's disease: phenotype and application

1 reference

12 December 2020

Size of the treatment effect on cognition of cholinesterase inhibition in Alzheimer's disease

1 reference

12 December 2020

Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE

1 reference

12 December 2020

Pharmacological profiles of peptide drug candidates for the treatment of Alzheimer's disease.

1 reference

12 December 2020

Interleukin-1 beta-induced expression of the prostaglandin E-receptor subtype EP3 in U373 astrocytoma cells depends on protein kinase C and nuclear factor-kappaB

1 reference

12 December 2020

Adjuvant-dependent modulation of Th1 and Th2 responses to immunization with beta-amyloid

1 reference

12 December 2020

MAPK-activated protein kinase 2 deficiency in microglia inhibits pro-inflammatory mediator release and resultant neurotoxicity. Relevance to neuroinflammation in a transgenic mouse model of Alzheimer disease

1 reference

12 December 2020

Pharmacological approaches of neurofibrillary degeneration

1 reference

12 December 2020

Secretase inhibitors for Alzheimer's disease: challenges of a promiscuous protease.

1 reference

12 December 2020

Understanding molecular mechanisms of proteolysis in Alzheimer's disease: progress toward therapeutic interventions

1 reference

12 December 2020

Economics of dementia and pharmacoeconomics of dementia therapy

1 reference

12 December 2020

Cholesterol, statins and dementia.

1 reference

12 December 2020

Presenilin-dependent "gamma-secretase" processing of deleted in colorectal cancer (DCC)

1 reference

12 December 2020

Statin therapy in Alzheimer's disease

1 reference

12 December 2020

Microglial activation facilitates Abeta plaque removal following intracranial anti-Abeta antibody administration

1 reference

12 December 2020

Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial

1 reference

12 December 2020

Allosteric sensitization of nicotinic receptors by galantamine, a new treatment strategy for Alzheimer's disease

1 reference

12 December 2020

A presenilin-1-dependent gamma-secretase-like protease mediates release of Notch intracellular domain

1 reference

12 December 2020

Metabolic regulation of brain Abeta by neprilysin.

1 reference

12 December 2020

Sulindac sulfide is a noncompetitive gamma-secretase inhibitor that preferentially reduces Abeta 42 generation

1 reference

12 December 2020

Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer's disease.

1 reference

12 December 2020

Clinical validity of A beta-protein deposition staging in brain aging and Alzheimer disease.

1 reference

12 December 2020

Notch activity influences the alphabeta versus gammadelta T cell lineage decision

1 reference

12 December 2020

Differential glycosylation regulates processing of lipoprotein receptors by gamma-secretase

1 reference

12 December 2020

Inhibition of beta-amyloid(40) fibrillogenesis and disassembly of beta-amyloid(40) fibrils by short beta-amyloid congeners containing N-methyl amino acids at alternate residues

1 reference

12 December 2020

A synthetic peptide blocking the apolipoprotein E/beta-amyloid binding mitigates beta-amyloid toxicity and fibril formation in vitro and reduces beta-amyloid plaques in transgenic mice.

1 reference

12 December 2020

Peroxisome proliferator-activated receptor-gamma ligands reduce neuronal inducible nitric oxide synthase expression and cell death in vivo

1 reference

12 December 2020

Rivastigmine and donepezil treatment in moderate to moderately-severe Alzheimer's disease over a 2-year period

1 reference

12 December 2020

Microglial expression of prostaglandin EP3 receptor in excitotoxic lesions in the rat striatum

1 reference

12 December 2020

Nasal administration of amyloid-beta peptide decreases cerebral amyloid burden in a mouse model of Alzheimer's disease.

1 reference

12 December 2020

The potential role of non-steroidal anti-inflammatory drugs in treating Alzheimer's disease

1 reference

12 December 2020

Intracellular Abeta42 activates p53 promoter: a pathway to neurodegeneration in Alzheimer's disease

1 reference

12 December 2020

Cholinesterase inhibitors used in the treatment of Alzheimer's disease: the relationship between pharmacological effects and clinical efficacy

1 reference

12 December 2020

Neuroprotection in Parkinson's disease: clinical trials

1 reference

12 December 2020

3D-Reconstruction of microglia and amyloid in APP23 transgenic mice: no evidence of intracellular amyloid

1 reference

12 December 2020

Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse

1 reference

12 December 2020

Clinical effects of Abeta immunization (AN1792) in patients with AD in an interrupted trial.

1 reference

12 December 2020

Cdk5 as a drug target for the treatment of Alzheimer's disease

1 reference

12 December 2020

Nectin-1alpha, an immunoglobulin-like receptor involved in the formation of synapses, is a substrate for presenilin/gamma-secretase-like cleavage

1 reference

12 December 2020

A new therapeutic target in Alzheimer's disease treatment: attention to butyrylcholinesterase

1 reference

12 December 2020

Galantamine for Alzheimer's disease

1 reference

12 December 2020

Gene vaccination to bias the immune response to amyloid-beta peptide as therapy for Alzheimer disease

1 reference

12 December 2020

Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer's disease

1 reference

12 December 2020

A multicenter, randomized, placebo controlled, multiple-dose, safety and pharmacokinetic study of AIT-082 (Neotrofin) in mild Alzheimer's disease patients

1 reference

12 December 2020

Effects of switching from an AChE inhibitor to a dual AChE-BuChE inhibitor in patients with Alzheimer's disease

1 reference

12 December 2020

Alpha-tocopherol: roles in prevention and therapy of human disease

1 reference

12 December 2020

Brain oxidative stress in animal models of accelerated aging and the age-related neurodegenerative disorders, Alzheimer's disease and Huntington's disease

1 reference

12 December 2020

Neurosteroid quantification in human brain regions: comparison between Alzheimer's and nondemented patients.

1 reference

12 December 2020

Dietary Cu stabilizes brain superoxide dismutase 1 activity and reduces amyloid Abeta production in APP23 transgenic mice

1 reference

12 December 2020

Inequalities in dementia care across Europe: key findings of the Facing Dementia Survey

1 reference

12 December 2020

Isolation and quantification of soluble Alzheimer's beta-peptide from biological fluids

1 reference

12 December 2020

Does lithium therapy protect against the onset of dementia?

1 reference

12 December 2020

Alzheimer's disease beta-amyloid peptide is increased in mice deficient in endothelin-converting enzyme

1 reference

12 December 2020

BACE knockout mice are healthy despite lacking the primary beta-secretase activity in brain: implications for Alzheimer's disease therapeutics

1 reference

12 December 2020

Peroxisome proliferator-activated receptor gamma-dependent repression of the inducible nitric oxide synthase gene

1 reference

12 December 2020

Relationship between dementia and nutrition-related factors and disorders: an overview

1 reference

12 December 2020

Cerebrolysin decreases amyloid-beta production by regulating amyloid protein precursor maturation in a transgenic model of Alzheimer's disease.

1 reference

12 December 2020

Medical significance of peroxisome proliferator-activated receptors.

1 reference

12 December 2020

Nonsteroidal Antiinflammatory Drugs and the Risk of Alzheimer's Disease

1 reference

12 December 2020

Vitamin E and donepezil for the treatment of mild cognitive impairment

1 reference

12 December 2020

A subset of NSAIDs lower amyloidogenic Abeta42 independently of cyclooxygenase activity

1 reference

12 December 2020

Oxidative stress in Alzheimer's disease: implications for prevention and therapy.

1 reference

12 December 2020

Donepezil for dementia due to Alzheimer's disease

1 reference

12 December 2020

Neuropathology of human Alzheimer disease after immunization with amyloid-beta peptide: a case report.

1 reference

12 December 2020

A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease.

1 reference

12 December 2020

Neuroimaging biomarkers for clinical trials of disease-modifying therapies in Alzheimer's disease

1 reference

12 December 2020

Proteolytic processing of low density lipoprotein receptor-related protein mediates regulated release of its intracellular domain

1 reference

12 December 2020

Memantine for dementia

1 reference

12 December 2020

Bifunctional drug derivatives of MAO-B inhibitor rasagiline and iron chelator VK-28 as a more effective approach to treatment of brain ageing and ageing neurodegenerative diseases

1 reference

12 December 2020

Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders

1 reference

12 December 2020

Strategies for disease modification in Alzheimer's disease

1 reference

12 December 2020

Impact of estrogen therapy on Alzheimer's disease: a fork in the road?

1 reference

12 December 2020

Hormone therapy and risk for dementia: where do we go from here?

1 reference

12 December 2020

Alzheimer's disease and NGF signaling

1 reference

12 December 2020

Nonsteroidal anti-inflammatory drugs for the prevention of Alzheimer's disease: a systematic review

1 reference

12 December 2020

Peripheral anti-A beta antibody alters CNS and plasma A beta clearance and decreases brain A beta burden in a mouse model of Alzheimer's disease

1 reference

12 December 2020

A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease

1 reference

12 December 2020

Inflammatory mechanisms in Alzheimer's disease: inhibition of beta-amyloid-stimulated proinflammatory responses and neurotoxicity by PPARgamma agonists.

1 reference

12 December 2020

Rivastigmine for Alzheimer's disease.

1 reference

12 December 2020

Loss of presenilin function causes impairments of memory and synaptic plasticity followed by age-dependent neurodegeneration

1 reference

12 December 2020

Technology evaluation: colostrinin, ReGen

1 reference

12 December 2020

Neprilysin regulates amyloid Beta peptide levels

1 reference

12 December 2020

Human antibodies against amyloid beta peptide: a potential treatment for Alzheimer's disease.

1 reference

12 December 2020

Neuropathology and pathogenesis of encephalitis following amyloid-beta immunization in Alzheimer's disease.

1 reference

12 December 2020

Antigonadotropins: a novel strategy to halt Alzheimer's disease progression

1 reference

12 December 2020

Functional gamma-secretase inhibitors reduce beta-amyloid peptide levels in brain

1 reference

12 December 2020

A CBP binding transcriptional repressor produced by the PS1/epsilon-cleavage of N-cadherin is inhibited by PS1 FAD mutations

1 reference

12 December 2020

10.2165/00003495-200666160-00004

Identifiers

DOI

1 reference

Dimensions Publication ID

15 August 2017

0 references

1 reference